J P Griffin. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug CostsDrug Prescriptions/economicsDrug Therapy/economicsHealth Care CostsHumansTime FactorsUnited Kingdom
Year: 1995 PMID: 10155325 DOI: 10.2165/00019053-199507050-00002
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981